Artal Group’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-405,784
| Closed | -$16.1M | – | 129 |
|
|
2024
Q1 | $16.1M | Buy |
405,784
+355,025
| +699% | +$14.1M | 0.41% | 30 |
|
|
2023
Q4 | $967K | Sell |
50,759
-1,142,271
| -96% | -$21.8M | 0.03% | 69 |
|
|
2023
Q3 | $13.7M | Hold |
1,193,030
| – | – | 0.59% | 26 |
|
|
2023
Q2 | $12.3M | Hold |
1,193,030
| – | – | 0.38% | 37 |
|
|
2023
Q1 | $9.21M | Hold |
1,193,030
| – | – | 0.55% | 42 |
|
|
2022
Q4 | $8.77M | Hold |
1,193,030
| – | – | 0.49% | 44 |
|
|
2022
Q3 | $8.59M | Buy |
1,193,030
+600,000
| +101% | +$4.32M | 0.37% | 43 |
|
|
2022
Q2 | $5.05M | Hold |
593,030
| – | – | 0.27% | 57 |
|
|
2022
Q1 | $5.32M | Hold |
593,030
| – | – | 0.22% | 72 |
|
|
2021
Q4 | $8.21M | Hold |
593,030
| – | – | 0.22% | 69 |
|
|
2021
Q3 | $6.33M | Hold |
593,030
| – | – | 0.14% | 99 |
|
|
2021
Q2 | $5.34M | Hold |
593,030
| – | – | 0.11% | 109 |
|
|
2021
Q1 | $6.29M | Hold |
593,030
| – | – | 0.11% | 105 |
|
|
2020
Q4 | $7.47M | Hold |
593,030
| – | – | 0.16% | 88 |
|
|
2020
Q3 | $5.21M | Buy |
+593,030
| New | +$5.21M | 0.13% | 83 |
|